tazobactam has been researched along with Sensitivity and Specificity in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerra Valero, YC; Lipman, J; Naicker, S; Ordenez Meija, JL; Parker, SL; Roberts, JA; Wallis, SC | 1 |
| An, G; Bach, T; D'Cunha, R; Li, P; Nalbant, D; Winokur, P; Young, BA; Zhang, J | 1 |
| Bonomo, RA; Chambers, HF; Chen, L; Domitrovic, TN; Evans, SR; Farmer, M; Fowler, VG; Hill, CB; Hujer, AM; Hujer, KM; Jacobs, MR; Kreiswirth, BN; Manca, C; Mediavilla, JR; Patel, R; Perez, F; Pitzer, KM; Tran, TTT; Wilson, BM | 1 |
| Bandettini, R; Barco, S; Cangemi, G; Castagnola, E; Maffia, A; Tripodi, G | 1 |
| Al-Attas, A; Belal, F; El-Enany, N; Nasr, JJ | 1 |
| Di Giovamberardino, G; Federici, G; Ferrannini, M; Pastore, A; Testore, GP | 1 |
| Metan, G | 1 |
| Ehrlich, M; Galla, TJ; Horch, RE; Kümmerer, K; Trittler, R | 1 |
| Burgess, DS; Nathisuwan, S | 1 |
| Bantar, C; Bertolini, P; Blázquez, N; Borda, N; Casellas, JM; Couto, E; Cudmani, N; Guerrera, J; Juárez, MJ; Littvik, A; López, T; Méndez, E; Notario, R; Ponce, G; Quinteros, M; Salamone, F; Sparo, M; Sutich, E; Tomé, G; Vaylet, S; Wolff, L | 1 |
| Burgess, DS; Hall, RG | 1 |
| Arzuaga, A; Gascón, AR; Isla, A; Martín, A; Maynar, J; Pedraz, JL; Solinís, MA; Toral, D | 1 |
| Wang, GJ; Xia, CH; Xiong, YQ | 1 |
| Bennett, KM; Dodds-Ashley, E; Hayward, TZ; Kaye, KS; Scarborough, JE; Sharpe, M; Vaslef, SN | 1 |
| Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL | 1 |
| Albert, G; Audran, M; Augey, V; Bressolle, F; Grosse, PY | 1 |
| Archontaki, HA; Marselos, SC | 1 |
17 other study(ies) available for tazobactam and Sensitivity and Specificity
| Article | Year |
|---|---|
A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent.
Topics: Calibration; Chromatography, High Pressure Liquid; Critical Illness; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasma; Renal Replacement Therapy; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam; Urine | 2018 |
Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 1: Assay Development and Validation.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Chromatography, Liquid; Humans; Meropenem; Piperacillin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam | 2018 |
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Tazobactam | 2019 |
Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
Topics: Adult; Anti-Bacterial Agents; Ceftazidime; Child; Chromatography, Liquid; Drug Monitoring; Humans; Limit of Detection; Linezolid; Meropenem; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tazobactam; Thienamycins | 2015 |
A green capillary zone electrophoresis method for the simultaneous determination of piperacillin, tazobactam and cefepime in pharmaceutical formulations and human plasma.
Topics: Cefepime; Cephalosporins; Dosage Forms; Electrophoresis, Capillary; Green Chemistry Technology; Humans; Linear Models; Penicillanic Acid; Piperacillin; Reproducibility of Results; Sensitivity and Specificity; Tazobactam | 2015 |
High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Humans; Penicillanic Acid; Piperacillin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tazobactam | 2009 |
The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?
Topics: Aspergillus; Cross Reactions; Galactose; Humans; Mannans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam | 2013 |
New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.
Topics: Adipose Tissue; Automation; Chromatography, High Pressure Liquid; Humans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam | 2002 |
Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
Topics: Adult; Anti-Bacterial Agents; Argentina; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitalization; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam | 2003 |
In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Culture Media, Conditioned; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam; Thienamycins | 2004 |
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
Topics: Anti-Bacterial Agents; Calibration; Chromatography, High Pressure Liquid; Hemofiltration; Humans; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Tazobactam; Ultrafiltration | 2005 |
An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.
Topics: Anti-Bacterial Agents; China; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Humans; Penicillanic Acid; Piperacillin; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam | 2007 |
Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
Topics: Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clinical Protocols; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Incidence; Intensive Care Units; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Probability; Retrospective Studies; Sensitivity and Specificity; Tazobactam; Treatment Outcome | 2007 |
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam | 1995 |
High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
Topics: Chromatography, High Pressure Liquid; Circadian Rhythm; Drug Stability; Enzyme Inhibitors; Humans; Linear Models; Penicillanic Acid; Penicillins; Piperacillin; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam; Temperature | 1996 |
Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
Topics: Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Particle Size; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Powders; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tazobactam | 2002 |